Zev A. Wainberg

机构：Santa Monica College, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Los Angeles Medical Center, California Medical Clinic for Headache, UCLA Jonsson Comprehensive Cancer Center · ORCID：0000-0002-7142-1246

发表论文 629 篇 · 总被引 24956 次 · h-index 72

代表论文

• Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (2026 · New England Journal of Medicine · 被引 33)
• The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer (2026 · The Lancet Oncology · 被引 7)
• Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study. (2026 · Journal of Clinical Oncology · 被引 5)
• Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial (2026 · Nature Medicine · 被引 5)
• The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer (2026 · Clinical Cancer Research · 被引 2)
• Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial (2026 · Nature Communications · 被引 2)